60 likes | 79 Views
Pandemic Influenza Vaccine. Monovalent vaccine A/California/07/2009 (H1N1) Voluntary vaccination program will begin in early October Public Health will coordinate vaccine distribution. Vaccine Supply. Federal Government Contract Five manufacturers TIV and LAIV
E N D
Pandemic Influenza Vaccine • Monovalent vaccine • A/California/07/2009 (H1N1) • Voluntary vaccination program will begin in early October • Public Health will coordinate vaccine distribution
Vaccine Supply • Federal Government Contract • Five manufacturers • TIV and LAIV • Adjuvanted and un-adjuvanted products • Preservative-free products • Doses purchased: 195 million • FDA approved products: 4 (as of 9/18/09) • Limited supplies, initially • Vaccine to be distributed continuously
Pandemic H1N1 Vaccine Recommendations*, ACIP, July 2009 * Unadjuvanted vaccine Pregnant women Household and caregiver contacts of children younger than 6 months of age Health care and emergency medical services personnel Children and young adults ages 6 months through 24 years Persons aged 25 through 64 years who have medical conditions which put them at high risk for complications or death from influenza
ACIP RecommendationsLimited Vaccine Supply Pregnant women People who live with/care for children <6mos Healthcare & EMS workers with direct patient contact Children 6 months - 4 years Children 5 – 18 years with chronic medical conditions
Vaccine Administration • Number of doses • Adults • 1 dose (likely) • Children < 10 years • 2 doses (likely) regardless of previous vaccination status • Three week interval (likely)